{"TopicDetails": {"type": 0, "ccm2Id": 31064968, "cftId": 0, "identifier": "IMI2-2014-02-02", "title": "Manufacturing capability", "publicationDateLong": 1415232000000, "callIdentifier": "H2020-JTI-IMI2-2014-02-single-stage", "callTitle": "IMI2 2nd Call for proposals: IMI2 Ebola and other filoviral haemorrhagic fevers programme", "callccm2Id": 31067020, "allowPartnerSearch": true, "frameworkProgramme": {"id": 31045243, "abbreviation": "H2020", "description": "Horizon 2020 Framework Programme"}, "programmeDivision": [{"id": 31047894, "abbreviation": "EU.3.1.", "description": "Health, demographic change and wellbeing"}, {"id": 31047893, "abbreviation": "EU.3.", "description": "Societal Challenges"}, {"id": 31062059, "abbreviation": "EU.3.1.7.", "description": "Innovative Medicines Initiative 2 (IMI2)"}, {"id": 31045244, "abbreviation": "EC", "description": "EC Treaty"}], "topicMGAs": [], "tags": ["Cold chain", "Haemorrhagic fever", "Manufacturing", "Ebola", "Filovirus", "Vaccine development", "Thermo-stability", "Diagnostics", "Phase I, II, III clinical trials", "Biosafety level laboratory", "Deployment of vaccines", "Adherence to vaccination regimen"], "keywords": ["Diagnostic and implantable devices, environmental", "Viruses", "Drug development, clinical phases", "Privacy", "Mobile devices", "Emerging Epidemics", "Virology", "Regulatory framework for innovation", "Public health and epidemiology", "Public Private Partnerships (PPP)", "Prevention and treatment of infection by pathogens", "Research integrity and research misconduct"], "flags": ["IntlCoop"], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "IMI2-RIA Research and Innovation action", "typeOfMGA": []}], "plannedOpeningDate": "06 November 2014", "submissionProcedure": {"id": 31094504, "abbreviation": "single-stage", "description": "single-stage"}, "deadlineDates": ["01 December 2014"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3272913": [{"action": "IMI2-2014-02-02 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "06 November 2014", "deadlineModel": "single-stage", "deadlineDates": ["01 December 2014"], "budgetYearMap": {"0": 280000000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2014-02-01 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "06 November 2014", "deadlineModel": "single-stage", "deadlineDates": ["01 December 2014"], "budgetYearMap": {"0": 280000000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2014-02-03 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "06 November 2014", "deadlineModel": "single-stage", "deadlineDates": ["01 December 2014"], "budgetYearMap": {"0": 280000000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2014-02-04 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "06 November 2014", "deadlineModel": "single-stage", "deadlineDates": ["01 December 2014"], "budgetYearMap": {"0": 280000000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2014-02-05 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "06 November 2014", "deadlineModel": "single-stage", "deadlineDates": ["01 December 2014"], "budgetYearMap": {"0": 280000000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["0"]}, "description": "<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p>Specific challenge </p><p>In view of the current epidemic, the WHO has identified the progression of vaccine candidates currently in development as an urgent public health need. Because Ebola vaccines are recombinant adenovirus or other viral-based vaccines and need to be produced in facilities meeting an appropriate biosafety level, manufacturing the quantity of vaccine doses necessary for large-scale clinical testing and that can be thereafter urgently deployed represents a major challenge.</p><p> Scope </p><p>The project(s) will work on scaling up the currently available production techniques to the necessary scale and will be fully compliant with good manufacturing practices (GMP) and biological safety level requirements.</p><p>a.\u00a0\u00a0\u00a0\u00a0\u00a0 Costs and milestones are requested for manufacturing activities at volumes in the range of:</p><ul>  <li>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 100,000 \u2013 250,000 vaccine courses</li>  <li>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 250,000 \u2013 2M vaccine courses</li>  <li>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2M \u2013 20M vaccine courses</li></ul><p>Consideration to Drug Substance manufacture (formulated vaccine bulk) and finished Drug Product (vialed vaccine doses) should be given. Alternative manufacturing platforms to those currently utilised, or process improvement activities to increase vaccine manufacturing yields, may also be proposed.</p><p>b.\u00a0\u00a0\u00a0\u00a0\u00a0 Production and release of finished Drug Product is currently foreseen as a key bottleneck.\u00a0 Based on current regulatory requirements, non-replicating viral vaccine vectors need to be filled in BSL-2 compliant manufacturing facilities.\u00a0 This limits the number of manufacturers (CMOs and pharmaceutical companies) that are able to offer their services for fill and finish of an Ebola vaccine.\u00a0 Proposals are sought to generate additional data to help provide the necessary scientific, technical and regulatory justifications to seek a reclassification of such vectors such that they require BSL-1 containment, thereby opening up the potential for more manufacturers to assist in responding to the current outbreak.</p><p>It is considered that an IMI2 JU financial contribution of 10-20 million and an EFPIA in-kind contribution of EUR 70-110 million would allow this specific challenge to be addressed appropriately. Nevertheless, this does not preclude submission and selection of proposals requesting other amounts.</p><p> Expected impact </p><p>The project will deliver a manufacturing platform to provide the capacity for producing the required number of vaccine doses in GMP quality. Getting this type of production capacity online will have impact more generally for European competitiveness in the area of biological production under appropriate biological safety level conditions.</p><p> Special informationSince the implementation of Phase I, II, and III clinical trials is linked to manufacturing capability, projects funded under Topics 1 and 2 of this Call are expected to work in collaboration to ensure maximal\u00a0 impact.</p>\n<SPAN class=\"topicdescriptionkind\">Cross-cutting Priorities</SPAN>:<p><a href=\"//ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-search;statusCodes=31094501,31094502,31094503;programCcm2Id=31045243;crossCuttingPriorityCode=IntlCoop;sortQuery=sortStatus;orderBy=asc\">International cooperation</a><br></p>\n", "conditions": "<p>Please read the <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/call_fiches/jtis/h2020-call-fiche14-2-imi2-ju_en.pdf\">IMI2 2nd Call Topic Text</a> for full details of this topic.</p>\r\n<p>Please note that submitting proposals for this call can only be done through the <a href=\"http://sofia.imi.europa.eu/\">IMI SOFIA software tool</a>.</p>\r\n<p>Please read carefully all provisions below before the preparation of your application.&nbsp;</p>\r\n<ol>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">List of countries and applicable rules for funding: </span></strong>described in <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/wp/2014_2015/annexes/h2020-wp1415-annex-a-countries-rules_en.pdf\">part A of the General Annexes</a> of the General Work Programme.<br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Eligibility and admissibility conditions:</span></strong> described in the <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/guides_for_applicants/jtis/h2020-guide-pse-imi-ju_en.pdf\">IMI2 Manual for evaluation, submission and grant award</a>. See also the <a href=\"http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:JOL_2014_174_R_0003\">Commission Delegated Regulation (EU) N&deg; 622/2014 of 14 February 2014</a><br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Evaluation&nbsp;</span></strong><br />\r\n    For a guide to the submission and evaluation process including evaluation criteria and procedure, scoring and threshold: please see the <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/guides_for_applicants/jtis/h2020-guide-pse-imi-ju_en.pdf\"><strong>IMI2</strong> Manual for submission, evaluation and grant award</a>.<br />\r\n    See also the IMI2 RIA&nbsp;Proposal Template and IMI2 RIA Evaluation Form in section 6, below.&nbsp; <br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Proposal page limits and layout: </span></strong>Please refer to IMI2 RIA Proposal Template in section 6, below.<br />\r\n    &nbsp;</li>\r\n    <li><span style=\"color: rgb(0,51,102)\"><strong>Indicative timetable for evaluation and grant agreement:</strong></span><br />\r\n    Information on the outcome of <strong>one-stage </strong>evaluation: maximum&nbsp;2 months from the final date for submission.<br />\r\n    Signature of grant agreements: maximum&nbsp;1 month from the date of informing successful applicants.<br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:</span></strong><br />\r\n    <a href=\"http://www.imi.europa.eu/sites/default/files/uploads/documents/IMI2_Call1/Summary_of_provisions_for_particip_2014.06.26.pdf\">Summary of the most relevant provisions for participating in IMI2 actions</a><br />\r\n    <a href=\"http://www.imi.europa.eu/sites/default/files/uploads/documents/IMI2_CallDocs/IMI2_proposal_template.pdf\">IMI2 RIA&nbsp;Proposal Template</a> <br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/call_ptef/ef/h2020-call-ef-imi2-ria_en.pdf\">IMI2 RIA Evaluation Form</a><br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/mga/jtis/h2020-mga-imi_en.pdf\">IMI2 Model Grant Agreement</a></li>\r\n</ol>\r\n<p>&nbsp;</p>", "supportInfo": "<div>\r\n<p>Contact the <strong><a href=\"http://www.imi.europa.eu/\">IMI Programme Office</a></strong>. E-mail: <a href=\"mailto:Infodesk@imi.europa.eu\"><strong>Infodesk@imi.europa.eu</strong></a> Tel.: +32 2 221 8181</p>\r\n<p>IMI JU <a href=\"mailto:sofia@imi.europa.eu\"><strong>IT Helpdesk</strong></a>&nbsp;- contact the SOFIA IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.</p>\r\n<p><a href=\"http://www.imi.europa.eu/content/states-representatives-groups\"><strong>IMI2 States Representative Group (SRG)</strong></a> - contact your SRG member for assistance</p>\r\n<p><a href=\"http://www.imi.europa.eu/content/partner-search\"><strong>IMI Partner Search Tool</strong></a> helps you find a partner organisation for your proposal</p>\r\n<p><a href=\"http://ec.europa.eu/research/participants/portal/desktop/en/support/national_contact_points.html\"><strong>National Contact Points (NCP)</strong></a> - contact your NCP for further assistance</p>\r\n<p><a href=\"http://een.ec.europa.eu/\"><strong>Enterprise Europe Network </strong></a>&ndash; national contact points' advice to businesses with focus on SMEs. The support includes guidance on the EU research funding.</p>\r\n<p><a href=\"http://ec.europa.eu/research/index.cfm?lg=en&amp;pg=enquiries\"><strong>Research Enquiry Service</strong></a> &ndash; ask questions about any aspect of European research and EU R&amp;I programmes</p>\r\n<p><strong>Ethics</strong> &ndash; for compliance with ethical issues, see the <a href=\"http://ec.europa.eu/research/participants/docs/h2020-funding-guide/cross-cutting-issues/ethics_en.htm\"><strong>Participant Portal</strong></a>&nbsp;and&nbsp;<a href=\"http://ec.europa.eu/research/science-society/index.cfm?fuseaction=public.topic&amp;id=1289&amp;lang=1\"><strong>Science and Society Portal</strong></a></p>\r\n<p><a href=\"http://ec.europa.eu/euraxess/pdf/brochure_rights/am509774CEE_EN_E4.pdf\"><strong>The European Charter for Researchers and the Code of Conduct for their recruitment</strong></a></p>\r\n<p><a href=\"http://www.cen.eu/cen/Services/Innovation/Pages/default.aspx\"><strong>CEN</strong></a> and <a href=\"http://www.cenelec.eu/aboutcenelec/whatwestandfor/fosterinnovation/randd.html\"><strong>CENELEC</strong></a>, the European Standards Organisations, advise you how to tackle standardisation in your project proposal. Contact CEN-CENELEC Research Helpdesk at <a href=\"mailto:research@cencenelec.eu\"><strong>research@cencenelec.eu</strong></a></p>\r\n</div>\r\n<p>&nbsp;</p>", "sepTemplate": "<p>Proposals must be submitted via the <strong>IMI electronic submission tool SOFIA </strong>(Submission OF Information Application) <a href=\"http://sofia.imi.europa.eu\">http://sofia.imi.europa.eu</a>. No other means of submission will be accepted.</p>\r\n<p><span style=\"color: #ff0000\"><strong>The SOFIA software tool is now open.</strong></span></p>\r\n<p>To access SOFIA, Applicant Consortium Coordinators will need to complete a Request for Access <a href=\"https://sofia.imi.europa.eu/Pages/RequestAccess.aspx\">https://sofia.imi.europa.eu/Pages/RequestAccess.aspx</a> to the tool.</p>\r\n<p>&nbsp;The proposal may be updated online prior to the submission deadline. Please note that the submit button must be pressed to submit the proposal for evaluation.</p>", "links": [{"callIdentifier": "H2020-JTI-IMI2-2014-02-single-stage", "status": "Closed", "criterionType": "SubFundingScheme", "criterionTypeDescription": "subfunding schemes", "criterionCode": "IMI2-RIA", "criterionDescription": "Research and Innovation action", "url": "https://sofia.imi.europa.eu", "startDate": "Nov 12, 2014 2:10:00 PM"}], "additionalDossiers": [], "infoPackDossiers": [{"callId": 6052, "id": 291064, "title": "IMI2 2nd Call Text", "sectionId": 6052, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 215022, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2014-02-02/1630119-imi2_call-2_text_en.pdf", "id": 1630119, "fileName": "IMI2_Call-2_TEXT_en.pdf", "common": false, "crc32": 2637167466}]}, {"callId": 6052, "id": 291065, "title": "IMI2 RIA Proposal Template", "sectionId": 6052, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 426859, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2014-02-02/1632615-imi2_proposal_template_en.pdf", "id": 1632615, "fileName": "IMI2_proposal_template_en.pdf", "common": false, "crc32": 2192056097}]}, {"callId": 6052, "id": 291066, "title": "IMI2 RIA Evaluation Form", "sectionId": 6052, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 526638, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2014-02-02/1630120-h2020-call-ef-imi2-ria_en.pdf", "id": 1630120, "fileName": "h2020-call-ef-imi2-ria_en.pdf", "common": false, "crc32": 703482679}]}, {"callId": 6052, "id": 291067, "title": "IMI2 Manual for evaluation, submission and grant award", "sectionId": 6052, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 522336, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2014-02-02/1630122-h2020-guide-pse-imi-ju_en.pdf", "id": 1630122, "fileName": "h2020-guide-pse-imi-ju_en.pdf", "common": false, "crc32": 3844090519}]}, {"callId": 6052, "id": 291068, "title": "Summary of the most relevant provisions for participating in IMI2 actions", "sectionId": 6052, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 617313, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2014-02-02/1630123-imi2_summary_of_provisions_en.pdf", "id": 1630123, "fileName": "IMI2_Summary_of_provisions_en.pdf", "common": false, "crc32": 2442866750}]}], "callDetailsJSONItem": {"additionalInfo": "<p>For full information on this call, please refer to the <a href=\"http://www.imi.europa.eu/content/imi-2-call-2-0\">Call 2 section of the IMI website</a>.</p>\r\n<p>Please note that submitting short proposals for this call can only by done through the <a href=\"https://sofia.imi.europa.eu/Pages/Default.aspx\"><strong>IMI SOFIA submission tool</strong></a>. This tool will open for submissions on 25 November 2014.&nbsp; Prior to this date, you may prepare your Full Proposal according to the <a href=\"http://www.imi.europa.eu/sites/default/files/uploads/documents/IMI2_CallDocs/IMI2_proposal_template.doc\">IMI2 RIA Proposal Template</a>.<br />\r\n&nbsp;</p>", "latestInfos": [{"approvalDate": "Feb 2, 2015 1:56:50 PM", "lastChangeDate": "Feb 2, 2015 1:56:25 PM", "content": "<p><strong>Call Submission Information:</strong></p>\r\n<p>Proposals submitted: 19<br />\r\nInadmissible &amp; ineligible proposals: 5<br />\r\nProposals&nbsp;recommended for funding: 8<br />\r\nPropoals not recommended for funding: 6</p>"}, {"approvalDate": "Nov 25, 2014 4:15:23 PM", "lastChangeDate": "Nov 25, 2014 3:09:53 PM", "content": "<p><span style=\"color: #ff0000\"><strong>The SOFIA&nbsp;submission tool is now open </strong></span>at <a href=\"http://sofia.imi.europa.eu\">http://sofia.imi.europa.eu</a></p>\r\n<p>To access SOFIA, Applicant Consortium Coordinators will need to complete a Request for Access: <a href=\"https://sofia.imi.europa.eu/Pages/RequestAccess.aspx\">https://sofia.imi.europa.eu/Pages/RequestAccess.aspx</a></p>\r\n<p>As of 21 November, the <a href=\"http://www.imi.europa.eu/sites/default/files/uploads/documents/IMI2_CallDocs/IMI2_proposal_template.doc\">proposal template </a>has now been updated to include the Ethics Issues Table. All consortia must complete the Ethics Issues Table; if you have already started to fill in the form using the old template, simply copy and paste the table across.</p>\r\n<p>Questions about the Ebola+ programme? Read our <a href=\"http://www.imi.europa.eu/sites/default/files/uploads/documents/IMI2Call2/Ebola_Call_FAQs_20141121.pdf\">Frequently Asked Questions</a> (version of 21 November 2014)</p>"}, {"approvalDate": "Nov 21, 2014 5:02:42 PM", "lastChangeDate": "Nov 21, 2014 4:59:35 PM", "content": "<p>The SOFIA&nbsp;submission tool is expected to open on 25 November 2014</p>\r\n<p>As of 21 November, the <a href=\"http://www.imi.europa.eu/sites/default/files/uploads/documents/IMI2_CallDocs/IMI2_proposal_template.doc\">proposal template </a>has now been updated to include the Ethics Issues Table. All consortia must complete the Ethics Issues Table; if you have already started to fill in the form using the old template, simply copy and paste the table across. Guidance on how to fill in the table can be found in this guide <br />\r\n&nbsp;</p>\r\n<p>Questions about the Ebola+ programme? Read our <a href=\"http://www.imi.europa.eu/sites/default/files/uploads/documents/IMI2Call2/Ebola_Call_FAQs_20141121.pdf\">Frequently Asked Questions</a> (version of 21 November 2014)</p>"}, {"approvalDate": "Nov 12, 2014 2:17:19 PM", "lastChangeDate": "Nov 12, 2014 2:17:19 PM", "content": "The submission session is now available for: IMI2-2014-02-01(IMI2-RIA), IMI2-2014-02-02(IMI2-RIA), IMI2-2014-02-03(IMI2-RIA), IMI2-2014-02-04(IMI2-RIA), IMI2-2014-02-05(IMI2-RIA)"}, {"approvalDate": "Nov 11, 2014 10:13:20 AM", "lastChangeDate": "Nov 11, 2014 10:13:06 AM", "content": "<p>&nbsp;</p>\r\n<p>Questions about the Ebola+ programme? Read our <a href=\"http://www.imi.europa.eu/sites/default/files/uploads/documents/IMI2Call2/Ebola_Call_FAQs_20141110.pdf\"><strong>Frequently Asked Questions</strong></a></p>\r\n<p>Want to learn more about the Ebola Call? Sign up for one of the <a href=\"http://www.imi.europa.eu/events/2014/11/02/ebola-webinars-2014\"><strong>webinars</strong></a> on 12 November or 17 November at 14:00 CET</p>\r\n<p>IMI&rsquo;s <a href=\"http://www.imi.europa.eu/content/partner-search\"><strong>Partner Search Tool</strong></a> allows people interested in applying for IMI Call to search for potential project partners. You can find and contact partners from industry and other sectors in the Partner Search Tool.</p>"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}